Works by Loberg, Lise I.

Results: 6
    1
    2

    Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.

    Published in:
    2018
    By:
    • Goss, Glenwood D.;
    • Vokes, Everett E.;
    • Gordon, Michael S.;
    • Gandhi, Leena;
    • Papadopoulos, Kyriakos P.;
    • Rasco, Drew W.;
    • Fischer, JuDee S.;
    • Chu, Katharine L.;
    • Ames, William W.;
    • Mittapalli, Rajendar K.;
    • Lee, Ho‐Jin;
    • Zeng, Jiewei;
    • Roberts‐Rapp, Lisa A.;
    • Loberg, Lise I.;
    • Ansell, Peter J.;
    • Reilly, Edward B.;
    • Ocampo, Christopher J.;
    • Holen, Kyle D.;
    • Tolcher, Anthony W.;
    • Lee, Ho-Jin
    Publication type:
    journal article
    3
    4
    5

    Strategies and Recommendations for Using a Data‐Driven and Risk‐Based Approach in the Selection of First‐in‐Human Starting Dose: An International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Assessment.

    Published in:
    Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1395, doi. 10.1002/cpt.2009
    By:
    • Leach, Michael W.;
    • Clarke, David O.;
    • Dudal, Sherri;
    • Han, Chao;
    • Li, Chunze;
    • Yang, Zheng;
    • Brennan, Frank R.;
    • Bailey, Wendy J.;
    • Chen, Yingxue;
    • Deslandes, Antoine;
    • Loberg, Lise I.;
    • Mayawala, Kapil;
    • Rogge, Mark C.;
    • Todd, Marque;
    • Chemuturi, Nagendra V.
    Publication type:
    Article
    6